Krystal Biotech Inc
NASDAQ:KRYS
| Market Cap (Intraday) | 5.30B |
| Current PE | 50.02 |
| Forward PE | 62.93 |
| 2yr Forward PE | 27.24 |
| 10-Day MA | $176.75 |
| 50-Day MA | $186.71 |
| 200-Day MA | $166.78 |
Krystal Biotech Inc Stock, NASDAQ:KRYS
2100 Wharton Street, Suite 701, Pittsburgh, Pennsylvania 15203
United States of America
Phone: +1.412.586.5830
Number of Employees: 229
Description
Krystal Biotech, Inc. engages in developing and commercializing pharmaceutical products. It offers the product, VYJUVEK. The company was founded by Krish S. Krishnan and Suma M. Krishnan on April 15, 2016 and is headquartered in Pittsburgh, PA.